{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T15:03:39Z","timestamp":1774969419810,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["cidjournal.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.clindermatol.2015.04.007","type":"journal-article","created":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T04:01:34Z","timestamp":1428638494000},"page":"456-461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Psoriasis inversa: A separate identity or a variant of psoriasis vulgaris?"],"prefix":"10.1016","volume":"33","author":[{"given":"Silje Haukali","family":"Omland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Gniadecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2015.04.007_bb0005","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.clindermatol.2007.08.007","article-title":"Psoriasis: Epidemiology","volume":"25","author":"Gudjonsson","year":"2007","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0010","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2340\/00015555-0253","article-title":"Comparison of clinical features of HLA-Cw*0602-positive and -negative psoriasis patients in a Han Chinese population","volume":"87","author":"Fan","year":"2007","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0015","first-page":"176","article-title":"Clinical analysis of 48 cases of inverse psoriasis: A hospital-based study","volume":"15","author":"Wang","year":"2005","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0020","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1365-2133.2006.07405.x","article-title":"European patient perspectives on the impact of psoriasis: The EUROPSO patient membership survey","volume":"155","author":"Dubertret","year":"2006","journal-title":"Br J Dermatol"},{"issue":"Suppl. 19","key":"10.1016\/j.clindermatol.2015.04.007_bb0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1468-3083.2005.01329.x","article-title":"How patients experience psoriasis: Results from a European survey","volume":"3","author":"Fouere","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0030","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1111\/j.1468-3083.2010.03663.x","article-title":"Genital psoriasis: A questionnaire-based survey on a concealed skin disease in the Netherlands","volume":"24","author":"Meeuwis","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0035","series-title":"Rook's Textbook of Dermatology","article-title":"Psoriasis","author":"Griffiths","year":"2004"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0040","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.clindermatol.2013.08.015","article-title":"Non-infectious inflammatory genital lesions","volume":"32","author":"Andreassi","year":"2014","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0045","series-title":"Skin Pathology","first-page":"79","article-title":"Tissue reaction patterns","author":"Weedon","year":"2002"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0050","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/bjd.12354","article-title":"Nail psoriasis: A questionnaire-based survey","volume":"169","author":"Klaassen","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0055","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1600-0625.2009.00871.x","article-title":"Psoriasis: Characterization of six different clinical phenotypes","volume":"18","author":"Guinot","year":"2009","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0060","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1023\/B:EJEP.0000020447.59150.f9","article-title":"Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients","volume":"19","author":"Mallbris","year":"2004","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0065","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1038\/sj.jid.5700410","article-title":"The risk of lymphoma in patients with psoriasis","volume":"126","author":"Gelfand","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0070","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S1473-3099(10)70101-8","article-title":"HIV-associated psoriasis: Pathogenesis, clinical features, and management","volume":"10","author":"Morar","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0075","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1258\/ijsa.2011.010525","article-title":"Particular clinical presentations of psoriasis in HIV patients","volume":"22","author":"Fernandes","year":"2011","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0080","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.11622\/smedj.2014062","article-title":"Ostraceous and inverse psoriasis with psoriatic arthritis as the presenting features of advanced HIV infection","volume":"55","author":"Castillo","year":"2014","journal-title":"Singapore Med J"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0085","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1365-2230.2005.01882.x","article-title":"Onset of flexural psoriasis during infliximab treatment for Crohn's disease","volume":"30","author":"Peramiquel","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0090","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.ad.2011.12.018","article-title":"Flexural or inverse psoriasis in a patient with hidradenitis suppurativa receiving treatment with infliximab","volume":"103","author":"Nuno-Gonzalez","year":"2012","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0095","doi-asserted-by":"crossref","first-page":"18558","DOI":"10.5070\/D3196018558","article-title":"Diseases associated with hidranitis suppurativa: Part 2 of a series on hidradenitis","volume":"19","author":"Scheinfeld","year":"2013","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0100","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1001\/archderm.141.12.1527","article-title":"Impact of obesity and smoking on psoriasis presentation and management","volume":"141","author":"Herron","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0105","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1046\/j.1365-2133.2003.05552.x","article-title":"Streptococcal throat infections and exacerbation of chronic plaque psoriasis: A prospective study","volume":"149","author":"Gudjonsson","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0110","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1439-0507.2007.01443.x","article-title":"Prevalence of Candida on the tongue and intertriginous areas of psoriatic and atopic dermatitis patients","volume":"51","author":"Leibovici","year":"2008","journal-title":"Mycoses"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0115","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/00015550310007463","article-title":"Microorganisms in intertriginous psoriasis: No evidence of Candida","volume":"83","author":"Flytstrom","year":"2003","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0120","first-page":"13","article-title":"Flexural versus plaque lesions in psoriasis: An immunohistochemical differentiation","volume":"15","author":"Vissers","year":"2005","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0125","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/j.1365-2133.2011.10249.x","article-title":"Quality of life and sexual health in patients with genital psoriasis","volume":"164","author":"Meeuwis","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0130","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/jsm.12119","article-title":"Assessment of female sexual function in patients with psoriasis","volume":"10","author":"Maaty","year":"2013","journal-title":"J Sex Med"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0135","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000338858","article-title":"Patients' experience of psoriasis in the genital area","volume":"224","author":"Meeuwis","year":"2012","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0140","series-title":"Fitzpatrick Dermatology in General Medicine","first-page":"2324","article-title":"Topical glucosteroids","author":"Valencia","year":"2003"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0145","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1067\/mjd.2001.110046","article-title":"Limited application of fluticasone propionate ointment, 0.005% in patients with psoriasis of the face and intertriginous areas","volume":"44","author":"Lebwohl","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0150","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5070\/D35ZK7V6CS","article-title":"The use of topical tacrolimus and pimecrolimus to treat psoriasis: A review","volume":"10","author":"Scheinfeld","year":"2004","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0155","doi-asserted-by":"crossref","first-page":"814","DOI":"10.5414\/CPP48814","article-title":"Evaluation of methylprednisolone aceponate, tacrolimus and combination thereof in the psoriasis plaque test using sum score, 20-MHz-ultrasonography and optical coherence tomography","volume":"48","author":"Buder","year":"2010","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0160","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jaad.2004.07.011","article-title":"Tacrolimus ointment is effective for facial and intertriginous psoriasis","volume":"51","author":"Lebwohl","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0165","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1365-2133.2007.08201.x","article-title":"Comparison of cutaneous tolerance and efficacy of calcitriol 3 microg g(-1) ointment and tacrolimus 0.3 mg g(-1) ointment in chronic plaque psoriasis involving facial or genitofemoral areas: A double-blind, randomized controlled trial","volume":"157","author":"Liao","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0170","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1001\/archderm.142.9.1138","article-title":"1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: A double-blind, randomized controlled study","volume":"142","author":"Kreuter","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0175","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.jaad.2004.06.010","article-title":"Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: A double-blind, randomized study","volume":"51","author":"Gribetz","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0180","first-page":"141","article-title":"Successful treatment of genital and facial psoriasis with tacrolimus ointment 0.1%","volume":"31","author":"Rallis","year":"2005","journal-title":"Drugs Exp Clin Res"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0185","first-page":"334","article-title":"Topical tacrolimus for the treatment of psoriasis on the face, genitalia, intertriginous areas and corporal plaques","volume":"5","author":"Martin Ezquerra","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0190","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1525-1470.2007.00341.x","article-title":"Tacrolimus ointment is effective for psoriasis on the face and intertriginous areas in pediatric patients","volume":"24","author":"Brune","year":"2007","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0195","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2310\/7750.2008.07055","article-title":"Efficacy and tolerability of topical tacrolimus ointment for the treatment of male genital psoriasis","volume":"12","author":"Bissonnette","year":"2008","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0200","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1067\/mjd.2003.169","article-title":"Tacrolimus ointment for the treatment of psoriasis on the face and intertriginous areas","volume":"48","author":"Freeman","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0205","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jaad.2005.05.036","article-title":"Topical tacrolimus in the treatment of inverse psoriasis in children","volume":"53","author":"Steele","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0210","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1046\/j.1365-2133.2003.05228.x","article-title":"Intraindividual comparison of the cutaneous safety and efficacy of calcitriol 3 microg g(-1) ointment and calcipotriol 50 microg g(-1) ointment on chronic plaque psoriasis localized in facial, hairline, retroauricular or flexural areas","volume":"148","author":"Ortonne","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0215","first-page":"127","article-title":"Calcipotriol cream in the treatment of flexural psoriasis","volume":"25","author":"Duweb","year":"2003","journal-title":"Int J Tissue React"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0220","first-page":"361","article-title":"Treatment of inverse psoriasis with excimer therapy and tacrolimus ointment","volume":"33","author":"Carrascosa","year":"2007","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0225","first-page":"21","article-title":"A case of inverse psoriasis successfully treated with adalimumab","volume":"23","author":"Jese","year":"2014","journal-title":"Acta Dermatovenerol Alp Panonica Adriat"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0230","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s13555-012-0015-5","article-title":"Inverse psoriasis involving genital skin folds: Successful therapy with dapsone","volume":"2","author":"Guglielmetti","year":"2012","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0235","first-page":"37","article-title":"Use of topical coal tar foam for the treatment of psoriasis in difficult-to-treat areas","volume":"3","author":"Zeichner","year":"2010","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0240","first-page":"74","article-title":"Treatment of inverse psoriasis with efalizumab","volume":"8","author":"George","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0245","first-page":"530","article-title":"Treatment of inverse psoriasis with the 308 nm excimer laser","volume":"28","author":"Mafong","year":"2002","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0250","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/archdermatol.2011.111","article-title":"Inverse psoriasis and hyperhidrosis of the axillae responding to botulinum toxin type A","volume":"147","author":"Saber","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0255","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1468-3083.2007.02457.x","article-title":"Botulinum toxin type-A for the treatment of inverse psoriasis","volume":"22","author":"Zanchi","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0260","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/09546630701341949","article-title":"Psoriasis of the face and flexures","volume":"18","author":"van de Kerkhof","year":"2007","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2015.04.007_bb0265","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jaad.2008.06.041","article-title":"Treatment of intertriginous psoriasis: From the Medical Board of the National Psoriasis Foundation","volume":"60","author":"Kalb","year":"2009","journal-title":"J Am Acad Dermatol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X15000711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X15000711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T09:16:16Z","timestamp":1717838176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X15000711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0738081X15000711"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2015.04.007","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psoriasis inversa: A separate identity or a variant of psoriasis vulgaris?","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2015.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}